Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronic acid in advanced NSCLC with and without bone metastasis
NCT00099541Phase 4Completed
- Sponsor
- Novartis
- Start
- Nov 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of zoledronic acid in non-small cell lung cancer (NSCLC), sponsored by Novartis. Started Nov 2004; status: completed.
02
Drugs
zoledronic acid
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00099541.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00099541.